Abstract:Copper complexes are considered as potential candidates for anticancer therapy and medical applications. In this paper, three new Cu(II) complexes, [Cu(IPY)2](ClO4)2·H2O (CuI1), [Cu(IPY)(L-Phe)H2O]ClO4·0.5H2O (CuI2) and [Cu(IPY)(L-Val)H2O]ClO4 (CuI3) (where IPY = 2-(1H-imidazol-2-yl)pyridine, L-Phe = L-phenylalanine, L-Val = L-valine), with good amphipathic properties were synthesized and characterized. The single crystal X-ray diffraction results revealed that CuI1 was four-coordinated, while CuI2 and CuI3 both adopted a five-coordinated tetragonal pyramidal configuration. Multi-spectral methods, viscosity experiment and molecular docking technique showed that three complexes interacted with DNA through insertion. The results of the gel electrophoresis experiments indicated that DNA was oxidatively cleaved by all the complexes in a concentration-dependent manner. Moreover, singlet oxygen (1O2), hydrogen peroxide (H2O2) and superoxide anion radicals (·O2−) were associated with oxidative cleavage of DNA. All the complexes also had good binding affinity with human serum albumin (HSA). The MB degradation assay revealed that all complexes could react with H2O2 to form ·OH through Fenton-like processes. The complexes displayed good antiproliferative activity against the tested human cancer cells in vitro, including cervical carcinoma cells (HeLa), liver cancer cells (HepG2 and BEL-7402) and gastric adenocarcinoma cells (SGC-7901), but showed lower toxicity to normal liver cells (LO2). The anticancer mechanism research revealed that CuI1, CuI2 and CuI3 arrested the cell cycle at S phase, elevated intracellular reactive oxygen species (ROS) levels and induced loss of mitochondrial membrane potential (MMP). The results indicated that these Cu(II) complexes could induce DNA damage and ROS-mediated mitochondrial dysfunction, leading to cancer cell apoptosis. Our work provided a theoretical basis for the design of new low-toxic and highly efficient anticancer Cu(II) complexes by incorporating biological metabolites and aromatic heterocycle ligands.

Synthesis, DNA binding, nuclease activity and cytotoxic studies of a wheel-shaped octanuclear copper(II) complex based on 1,2,4-triazole

Synthesis, X‐ray Crystal Structures, DNA Binding and Nuclease Activities of Two Novel 1,2,4‐triazole‐based CuII Complexes

A novel 1,2,4-triazole-based copper(II) complex: Synthesis, characterization, magnetic property and nuclease activity

Syntheses and Crystal Structures of Tetracopper(Ii) Complexes Bridged by Asymmetric N,N '-Bis(substituted)oxamides: Molecular Docking, Dna-Binding and in Vitro Anticancer Activity

Synthesis, Crystal Structure, DNA Interaction and Anticancer Activity of Tridentate Copper(ii) Complexes.

Synthesis and structure of a new tetracopper(II) complex with N -benzoate- N′ -[2-(2-hydroxyethylamino)ethyl]oxamide as bridging ligand: In vitro anticancer activities and DNA- and BSA-binding studies

Synthesis, DNA interaction and anticancer activity of copper(II) complexes with 4'-phenyl-2,2':6',2″-terpyridine derivatives.

Synthesis and structure elucidation of new μ-oxamido-bridged dicopper(II) complex with in vitro anticancer activity: A combined study from experiment verification and docking calculation on DNA/protein-binding property.

Synthesis and structure of new tetracopper(II) complexes bridged by 2-{N'-[2-(dimethylamino)ethyl]oxamido}benzoate: DNA-binding and anticancer activity.

DNA BINDING, IN VITRO CYTOTOXICITY AND ANTICANCER DRUG MECHANISM OF COPPER(II) COMPLEX CONTAINING PYRIDYL-TRIAZINE LIGAND

Synthesis and Crystal Structure of a New Copper(ii) Complex with N,N′-(4,4′-bithiazole-2,2′-diyl)diacetimidamide As Ligand: Molecular Docking, DNA-binding and Cytotoxicity Activity Studies

Synthesis and structure of a new tetracopper(II) complex bridged both by oxamido and phenolato groups: Cytotoxic activity, and reactivity towards DNA and BSA

Insights into Structure and Biological Activity of Copper(II) and Zinc(II) Complexes with Triazolopyrimidine Ligands

Synthesis and Structure of a New Ternary Monocopper(ii) Complex Containing Mixed Ligands of 2,2′‐diamino‐4,4′‐bithiazole and Picrate: in Vitro Anticancer Activity, Molecular Docking and Reactivity Towards DNA

Functional copper complexes with benzofurans tridentate ligand: Synthesis, crystal structure, DNA binding and anticancer studies

Synthesis, Structure, Cytotoxic Activities and DNA-binding Properties of Tetracopper(ii) Complexes with Dissymmetrical N,N′-bis(substituted)oxamides As Ligands

A series of DNA targeted Cu (II) complexes containing 1,8-naphthalimide ligands: Synthesis, characterization and in vitro anticancer activity

Synthesis, DNA binding and anticancer properties of new Cu(II) and Zn(II) complexes of a Schiff base ligand containing a triphenylphosphonium as a lipophilic cation

Syntheses and structures of new trimetallic complexes bridged by N-(5-chloro-2-hydroxyphenyl)-N'-[3-(dimethylamino)propyl]oxamide: cytotoxic activities, and reactivities towards DNA and protein.

Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1H-imidazol-2-yl)pyridine and amino acids

Synthesis, characterization and biological activity of novel copper complexes containing a β-carboline derivative and amino acids